Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel photoredox catalysis route for Obitavir reduces steps and metal use. Enhances supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN107353245B reveals metal-free photocatalytic route. Delivers high purity quinoline intermediates with significant supply chain and cost advantages for global buyers.
Novel copper-catalyzed dimerization method offers high atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN109912487B reveals a novel non-transition metal catalytic route for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Novel telescoping route for DPP1 inhibitor intermediate ensures high purity and scalable production for global pharmaceutical supply chains seeking cost reduction.
Novel visible-light mediated method for 1,1-diarylalkanes. High yield, mild conditions. Ideal for pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN113548950B reveals green ultrasound-assisted aqueous synthesis. Delivers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Patent CN109574797B reveals a green aqueous route for S-Int A. Achieve 99.9% ee and simplified purification for antifungal API manufacturing.
Efficient 4-step synthesis of Mycophenolic acid-13CD3 via Mitsunobu reaction. Cost-effective route for pharmacokinetic research intermediates.
Patent CN103864918A reveals efficient fragment condensation for liraglutide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Advanced purification method for Cefotiam Hexetil Hydrochloride ensuring over 98.5 percent purity and reduced isomers for reliable antibiotic manufacturing.
Patent CN106676573A reveals green electrochemical route for aromatic nitriles. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced purification method for Cefotiam Hexetil Hydrochloride using reducing agents ensures high purity and yield. Ideal for antibiotic manufacturing supply chains.
Patent CN117700410B reveals a high-yield synthesis for Paliperidone intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102348710B reveals zinc powder deprotection for meropenem. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel 5-step route for Belumosudil Mesylate. Higher yield, scalable process for cGVHD treatment. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Novel synthesis method for Paxlovid intermediate offering high purity and scalable production capabilities for global pharmaceutical supply chains and significant cost efficiency.
Novel catalytic route for (S)-Oxiracetam ensures 99.8% purity and 80% yield. Cost-effective scalable manufacturing for pharmaceutical supply chains.